Its latest quarterly revenue reached 677.64M, representing a year-over-year increase of 13.33%, while its net profit experienced a year-over-year increase of 103.75%.
The current valuation score of Amcon Distributing Co is 8.62. Its current P/E ratio is 141.17, which is 39.00% below the recent high of 196.23 and 100.00% above the recent low of 0.00.
No earnings forecast score is currently available for Amcon Distributing Co. The Food & Drug Retailing industry's average is 7.52.
The current price momentum score of Amcon Distributing Co is 9.16. Currently, the stock price is trading between the resistance level at 95.60 and the support level at 19.84, making it suitable for range-bound swing trading.
The latest institutional shareholding proportion is 10.63%, representing a quarter-over-quarter decrease of 7.94%. The largest institutional shareholder is James Simons, holding a total of 14.00K shares, representing 0.00% of shares outstanding, with 15.89% decrease in holdings.
The current risk assessment score of Amcon Distributing Co is 2.14. The company's beta value is -0.13. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.